New tool aims to speed up thyroid hormone dosing after surgery

NCT ID NCT06455371

Recruiting now Symptom relief Sponsor: University Hospital of North Norway Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 08, 2026 · Updated 21 times

Summary

This study tests a decision support tool that uses early blood tests to predict the best dose of levothyroxine (thyroid hormone) after thyroid removal surgery. Normally, finding the right dose takes months of trial and error. The tool aims to get patients to the correct dose faster, which may improve their symptoms and quality of life. About 240 adults who had their thyroid removed for cancer or benign nodules will take part.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for THYROID CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Haukeland University Hospital
RECRUITING

Bergen, Norway

Contact Phone: •••-•••-•••• Email: •••••@•••••
Oslo University Hospital
RECRUITING

Oslo, Norway

Contact Phone: •••-•••-•••• Email: •••••@•••••
University Hospital of North Norway
RECRUITING

Tromsø, 9010, Norway

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

HYPOTHYROIDISM THYROID THYROID CANCER